Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Prostatic Neoplasms 1Oropharyngeal Neoplasms 1Neoplasm Metastasis 1Lung Neoplasms 1Laryngeal Neoplasms 1Inflammatory Breast Neoplasms 1Hypopharyngeal Neoplasms 1Hyperthermia 1Head and Neck Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Adenocarcinoma, Bronchiolo-Alveolar 1

Interventions

Trastuzumab 3Cyclophosphamide 3pembrolizumab 2Radiotherapy 2Filgrastim 2Epirubicin 2Carboplatin 2tipifarnib 1pegfilgrastim 1olaparib 1aldesleukin 1Thiotepa 1Tamoxifen 1Semaxinib 1Peripheral Blood Stem Cell Transplantation 1Interleukin-12 Subunit p35 1Interleukin-12 1Immunohistochemistry 1Fluorouracil 1Fluorescent Antibody Technique 1Flow Cytometry 1Doxorubicin 1Docetaxel 1Diathermy 1Capecitabine 1Biopsy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Inflammatory Breast Neoplasms × Diathermy × Clear all
NCT00346229 2016-03-22

Temperature-Sensitive Liposomal Doxorubicin and Hyperthermia in Treating Women With Locally Recurrent Breast Cancer

Duke University

Phase 1 Terminated
29 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡